Brain Res Bull. 2010 Jan 15;81(1):3-6.

Valproic acid as a promising agent to combat Alzheimer's disease.

Source

Shandong Provincial Research Center for Bioinformatic Engineering and Technique, Center for Advanced Study, Shandong University of Technology, Zibo 255049, PR China. sleevexz@sdut.edu.cn

Abstract

Alzheimer's disease (AD) is one of the most threatening diseases to the elderly population at present. However, there is no yet efficient therapeutic method to AD. Recently, accumulating evidence indicates that valproic acid (VPA), a widely used mood stabilizer and antiepileptic drug, has neuroprotective potential relevant to AD. Moreover, VPA can induce neurogenesis of neural progenitor/stem cells both in vitro and in vivo via multiple signaling pathways. Therefore, it is suggested that VPA is a promising agent to combat AD.

PMID:: 19748552; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Molecular Biology Databases

VALPROIC ACID - HSDB

Supplemental Content

Related citations

Review Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent. [Curr Alzheimer Res. 2006]
Review Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent.
Brinton RD, Wang JM. Curr Alzheimer Res. 2006 Jul; 3(3):185-90.
The dentate gyrus neurogenesis: a therapeutic target for Alzheimer's disease. [Acta Neuropathol. 2003]
The dentate gyrus neurogenesis: a therapeutic target for Alzheimer's disease.
Tatebayashi Y, Lee MH, Li L, Iqbal K, Grundke-Iqbal I. Acta Neuropathol. 2003 Mar; 105(3):225-32. Epub 2002 Nov 19.
Review [Neurogenesis as a therapeutic target for Alzheimer's disease]. [Rev Neurol. 2009]
Review [Neurogenesis as a therapeutic target for Alzheimer's disease].
Fernández-Verdecia CI, Díaz del Guante MA, Castillo-Díaz L, Alvarez-Blanco J. Rev Neurol. 2009 Aug 16-31; 49(4):193-201.
Chronic dietary administration of valproic acid protects neurons of the rat nucleus basalis magnocellularis from ibotenic acid neurotoxicity. [Neurotox Res. 2009]
Chronic dietary administration of valproic acid protects neurons of the rat nucleus basalis magnocellularis from ibotenic acid neurotoxicity.
Eleuteri S, Monti B, Brignani S, Contestabile A. Neurotox Res. 2009 Feb; 15(2):127-32. Epub 2009 Mar 4.
Review Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. [Curr Mol Pharmacol. 2009]
Review Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection.
Monti B, Polazzi E, Contestabile A. Curr Mol Pharmacol. 2009 Jan; 2(1):95-109.

See reviews... See all...

Cited by 2 PubMed Central articles

The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway. [J Biol Chem. 2010]
The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway.
Belyaev ND, Kellett KA, Beckett C, Makova NZ, Revett TJ, Nalivaeva NN, Hooper NM, Turner AJ. J Biol Chem. 2010 Dec 31; 285(53):41443-54. Epub 2010 Oct 20.
Update on the pharmacological treatment of Alzheimer's disease. [Curr Neuropharmacol. 2010]
Update on the pharmacological treatment of Alzheimer's disease.
Massoud F, Gauthier S. Curr Neuropharmacol. 2010 Mar; 8(1):69-80.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Valproic acid as a promising agent to combat Alzheimer's disease.
Valproic acid as a promising agent to combat Alzheimer's disease.
Brain Res Bull. 2010 Jan 15 ;81(1):3-6.

PubMed
A behavioral weight-loss intervention for persons with serious mental illness in...
A behavioral weight-loss intervention for persons with serious mental illness in psychiatric rehabilitation centers.
Int J Obes (Lond). 2011 Aug ;35(8):1114-23. doi: 10.1038/ijo.2010.224. Epub 2010 Nov 2 .

PubMed
Painting "mania".
Painting "mania".
J Affect Disord. 2011 Feb ;128(3):319-20. Epub 2010 Aug 7 .

PubMed
Alcohol-induced blackout. Phenomenology, biological basis, and gender difference...
Alcohol-induced blackout. Phenomenology, biological basis, and gender differences.
J Addict Med. 2010 Jun ;4(2):61-73.

PubMed
Brain mechanisms of proactive interference in working memory.
Brain mechanisms of proactive interference in working memory.
Neuroscience. 2006 Apr 28 ;139(1):181-93. Epub 2005 Dec 5 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: